Ovid Therapeutics
OVID
OVID
80 hedge funds and large institutions have $131M invested in Ovid Therapeutics in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 30 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
37% less call options, than puts
Call options by funds: $1.78M | Put options by funds: $2.83M
40% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 30
Holders
80
Holding in Top 10
1
Calls
$1.78M
Puts
$2.83M
Top Buyers
| 1 | +$3.95M | |
| 2 | +$3.42M | |
| 3 | +$2.99M | |
| 4 |
Two Sigma Investments
New York
|
+$1.13M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$835K |
Top Sellers
| 1 | -$9.77M | |
| 2 | -$4.09M | |
| 3 | -$2.49M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.89M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.56M |